A detailed history of Sargent Bickham Lagudis LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 179,151 shares of PFE stock, worth $4.73 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
179,151
Previous 179,367 0.12%
Holding current value
$4.73 Million
Previous $7.85 Million 17.0%
% of portfolio
0.76%
Previous 0.7%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$41.75 - $54.5 $9,018 - $11,772
-216 Reduced 0.12%
179,151 $0
Q3 2022

Oct 27, 2022

SELL
$43.76 - $53.42 $35,664 - $43,537
-815 Reduced 0.45%
179,367 $7.85 Million
Q2 2022

Jul 13, 2022

SELL
$46.53 - $55.17 $6.55 Million - $7.77 Million
-140,869 Reduced 43.88%
180,182 $9.45 Million
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $56,364 - $69,842
1,232 Added 0.39%
321,051 $16.6 Million
Q4 2021

Jan 18, 2022

SELL
$41.32 - $61.25 $417,373 - $618,686
-10,101 Reduced 3.06%
319,819 $18.9 Million
Q3 2021

Nov 05, 2021

BUY
$39.25 - $50.42 $180,903 - $232,385
4,609 Added 1.42%
329,920 $14.2 Million
Q2 2021

Jul 19, 2021

SELL
$35.91 - $40.68 $85,753 - $97,143
-2,388 Reduced 0.73%
325,311 $12.7 Million
Q1 2021

May 24, 2021

BUY
$33.49 - $37.77 $58,071 - $65,493
1,734 Added 0.53%
327,699 $11.9 Million
Q4 2020

May 24, 2021

SELL
$33.47 - $42.56 $58,036 - $73,799
-1,734 Reduced 0.53%
325,965 $12 Million
Q4 2020

May 24, 2021

BUY
$33.47 - $42.56 $430,892 - $547,917
12,874 Added 4.09%
327,699 $11.9 Million
Q3 2020

Sep 01, 2021

BUY
$31.75 - $37.25 $113,538 - $133,206
3,576 Added 1.15%
314,825 $11.6 Million
Q2 2020

Sep 07, 2021

BUY
$30.12 - $36.54 $753 - $913
25 Added 0.01%
311,249 $10.2 Million
Q1 2020

Sep 07, 2021

BUY
$27.03 - $38.62 $7.9 Million - $11.3 Million
292,401 Added 1553.42%
311,224 $10.2 Million
Q4 2019

Sep 14, 2021

BUY
$32.92 - $37.36 $53,725 - $60,971
1,632 Added 9.49%
18,823 $738,000
Q3 2019

Sep 14, 2021

BUY
$32.49 - $42.13 $24,302 - $31,513
748 Added 4.55%
17,191 $618,000
Q2 2019

Sep 13, 2021

SELL
$36.98 - $41.52 $13,941 - $15,653
-377 Reduced 2.24%
16,443 $712,000
Q1 2019

Sep 13, 2021

SELL
$37.5 - $41.2 $19,087 - $20,970
-509 Reduced 2.94%
16,820 $714,000
Q4 2018

Sep 13, 2021

BUY
$38.47 - $43.86 $35,392 - $40,351
920 Added 5.61%
17,329 $756,000
Q3 2018

Sep 13, 2021

BUY
$34.47 - $41.81 $15,028 - $18,229
436 Added 2.73%
16,409 $723,000
Q2 2018

Sep 13, 2021

SELL
$32.98 - $35.16 $36,739 - $39,168
-1,114 Reduced 6.52%
15,973 $579,000
Q1 2018

Sep 13, 2021

SELL
$31.91 - $37.02 $48,981 - $56,825
-1,535 Reduced 8.24%
17,087 $606,000
Q4 2017

Sep 13, 2021

SELL
$33.26 - $35.29 $103,405 - $109,716
-3,109 Reduced 14.31%
18,622 $674,000
Q3 2017

Sep 13, 2021

SELL
$31.0 - $34.15 $13,082 - $14,411
-422 Reduced 1.9%
21,731 $776,000
Q2 2017

Sep 13, 2021

BUY
N/A
685 Added 3.19%
22,153 $744,000
Q1 2017

Sep 13, 2021

BUY
N/A
1,298 Added 6.44%
21,468 $734,000
Q4 2016

Sep 13, 2021

SELL
N/A
-1,055 Reduced 4.97%
20,170 $655,000
Q3 2016

Sep 13, 2021

BUY
N/A
2,518 Added 13.46%
21,225 $719,000
Q2 2016

Sep 07, 2021

BUY
N/A
4,201 Added 28.96%
18,707 $659,000
Q1 2016

Sep 07, 2021

BUY
N/A
14,506
14,506 $430,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.